KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to New Jersey

S4017 • 2026

Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

Budget
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Vitale, Joseph F.
Last action
2026-03-19
Official status
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

What This Bill Does

  • Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.
  • Topic: Health, Human Services and Senior Citizens Fiscal note: This bill has been certified by OLS for a fiscal note.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-03-19 New Jersey Legislature

    Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Official Summary Text

Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.
Topic:
Health, Human Services and Senior Citizens
Fiscal note:
This bill has been certified by OLS for a fiscal note.

Current Bill Text

Read the full stored bill text 
S4017

SENATE, No. 4017

STATE OF NEW JERSEY

222nd LEGISLATURE

�

INTRODUCED MARCH 19, 2026

Sponsored by:

Senator� JOSEPH F. VITALE

District 19 (Middlesex)

SYNOPSIS

���� Requires DOH to purchase xylazine test strips to be
distributed to entities that provide authorized harm reduction services; makes
appropriation.

CURRENT VERSION OF TEXT

���� As introduced.

��

An Act

concerning xylazine test strips, supplementing
Title 26 of the Revised Statutes, and making an appropriation.

����
Be It
Enacted
by the Senate and General Assembly of
the State of New Jersey:

���� 1.� a.� The Commissioner of
Health shall establish a program in the Department of Health with the purpose
of purchasing and distributing xylazine test strips to entities providing
authorized harm reduction services in the State pursuant to P.L.2006, c.99
(C.26:5C-25 et al.).

���� b.� In implementing the
program, the department shall:

���� (1)�� oversee the bulk
purchasing and the distribution of xylazine test strips to entities that
provide authorized harm reduction services, upon request by the entity; and

���� (2) establish and maintain an
Internet website that provides information to the public concerning xylazine
test strips and the availability of xylazine test strips through entities
providing authorized harm reduction services in the State.

���� c.� The program established
pursuant to this section shall be supported by such federal funds as may be
available for this purpose, as well as by any funds appropriated to the
department to implement the purposes of this act.

���� 2.� The Commissioner of Health
may adopt rules and regulations, pursuant to the �Administrative Procedure
Act,� P.L.1968, c.410 (C.52:14B-1 et seq.), as are necessary to implement the
provisions of this act.

���� 3.� There is appropriated from
the General Fund to the Department of Health such sums as are necessary to
implement the provisions of this act.

����

���� 4.� This act shall take effect
immediately.

STATEMENT

���� This bill requires the Commissioner
of Health to establish a program in the Department of Health (department) with
the purpose of purchasing and distributing xylazine test strips to entities
providing authorized harm reduction services in the State.

���� In implementing the program,
the department will:� oversee the bulk purchasing and the distribution of
xylazine test strips to entities that provide harm reduction services, upon
request by the entity; and establish and maintain an Internet website that provides
information to the public concerning xylazine test strips and the availability
of xylazine test strips through entities providing harm reduction services in
the State.

���� The program will be supported
by such federal funds as may be available, as well as by any funds appropriated
to the department to implement the purposes of the bill.

���� The bill appropriates from the
General Fund to the Department of Health such sums as are necessary to
implement the provisions of the bill.